+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Glycated Hemoglobin Testing Market by Type (Laboratory Based Tests, Point-Of-Care Test), Technique (Boronate Affinity Chromatography, Direct Enzymatic Assay, High-Performance Liquid Chromatography), End-User - Forecast 2024-2030- Product Image
Global Glycated Hemoglobin Testing Market by Type (Laboratory Based Tests, Point-Of-Care Test), Technique (Boronate Affinity Chromatography, Direct Enzymatic Assay, High-Performance Liquid Chromatography), End-User - Forecast 2024-2030- Product Image
Sale

Global Glycated Hemoglobin Testing Market by Type (Laboratory Based Tests, Point-Of-Care Test), Technique (Boronate Affinity Chromatography, Direct Enzymatic Assay, High-Performance Liquid Chromatography), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904570
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Glycated Hemoglobin Testing Market size was estimated at USD 686.36 million in 2023, USD 754.13 million in 2024, and is expected to grow at a CAGR of 9.96% to reach USD 1,334.83 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Glycated Hemoglobin Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Glycated Hemoglobin Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Glycated Hemoglobin Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l, Abbott Laboratories Inc., ARKRAY, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Daiichi Biotech Services Sdn. Bhd., Danaher Corporation, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc., EKF Diagnostics Holdings plc, F. Hoffmann-La Roche AG, Sebia, Siemens AG, TaiDoc Technology Corporation, Tosoh Corporation, and Trinity Biotech.

Market Segmentation & Coverage

This research report categorizes the Glycated Hemoglobin Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Laboratory Based Tests
    • Point-Of-Care Test
  • Technique
    • Boronate Affinity Chromatography
    • Direct Enzymatic Assay
    • High-Performance Liquid Chromatography
    • Immunoassay
  • End-User
    • Academic & Research Institutes
    • Diagnostic Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Glycated Hemoglobin Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Glycated Hemoglobin Testing Market?
  3. What are the technology trends and regulatory frameworks in the Glycated Hemoglobin Testing Market?
  4. What is the market share of the leading vendors in the Glycated Hemoglobin Testing Market?
  5. Which modes and strategic moves are suitable for entering the Glycated Hemoglobin Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Glycated Hemoglobin Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of various chronic diseases such as diabetes globally
5.1.1.2. Rising geriatric population leads to higher vulnerability for diseases
5.1.1.3. Rapid adoption attributed to patient self-care solutions
5.1.2. Restraints
5.1.2.1. High cost pertinent to glycated hemoglobin testing equipment
5.1.3. Opportunities
5.1.3.1. Emerging demand for home healthcare market such as rapid diagnostic tests and PCOT
5.1.3.2. Ongoing R&D activities for early diagnosis and efficient disease management
5.1.4. Challenges
5.1.4.1. Limitation of HbA1c tests and availability of substitutes
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Glycated Hemoglobin Testing Market, by Type
6.1. Introduction
6.2. Laboratory Based Tests
6.3. Point-Of-Care Test
7. Glycated Hemoglobin Testing Market, by Technique
7.1. Introduction
7.2. Boronate Affinity Chromatography
7.3. Direct Enzymatic Assay
7.4. High-Performance Liquid Chromatography
7.5. Immunoassay
8. Glycated Hemoglobin Testing Market, by End-User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Diagnostic Centers
8.4. Hospitals
9. Americas Glycated Hemoglobin Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Glycated Hemoglobin Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Glycated Hemoglobin Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. A. Menarini Diagnostics s.r.l
13.1.2. Abbott Laboratories Inc.
13.1.3. ARKRAY, Inc.
13.1.4. Beckman Coulter, Inc.
13.1.5. Bio-Rad Laboratories, Inc.
13.1.6. Daiichi Biotech Services Sdn. Bhd.
13.1.7. Danaher Corporation
13.1.8. DiaSys Diagnostic Systems GmbH
13.1.9. Diazyme Laboratories, Inc.
13.1.10. EKF Diagnostics Holdings plc
13.1.11. F. Hoffmann-La Roche AG
13.1.12. Sebia
13.1.13. Siemens AG
13.1.14. TaiDoc Technology Corporation
13.1.15. Tosoh Corporation
13.1.16. Trinity Biotech
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLYCATED HEMOGLOBIN TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLYCATED HEMOGLOBIN TESTING MARKET DYNAMICS
FIGURE 7. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
FIGURE 10. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. GLYCATED HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. GLYCATED HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. GLYCATED HEMOGLOBIN TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY LABORATORY BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY POINT-OF-CARE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 9. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY BORONATE AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY DIRECT ENZYMATIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 14. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 29. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 46. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 49. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 101. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 113. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 116. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. GLYCATED HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. GLYCATED HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. GLYCATED HEMOGLOBIN TESTING MARKET LICENSE & PRICING

Companies Mentioned

  • A. Menarini Diagnostics s.r.l
  • Abbott Laboratories Inc.
  • ARKRAY, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Daiichi Biotech Services Sdn. Bhd.
  • Danaher Corporation
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche AG
  • Sebia
  • Siemens AG
  • TaiDoc Technology Corporation
  • Tosoh Corporation
  • Trinity Biotech

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 754.13 Million
Forecasted Market Value ( USD ) by 2030 $ 1334.83 Million
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Glycated Hemoglobin Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Glycated Hemoglobin Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 100 Pages
  • Global
From
Glycated Haemoglobin Testing Equipment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Glycated Haemoglobin Testing Equipment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 96 Pages
  • Global
From
Global Hemoglobin A1c Analyzer Market by Product (Bench-top Analyzers, Handheld Analyzers, Reagents & Consumables), Technology (Chemical Methods, Separation Methods), Type, Distribution Channel, End User - Forecast 2024-2030 - Product Image

Global Hemoglobin A1c Analyzer Market by Product (Bench-top Analyzers, Handheld Analyzers, Reagents & Consumables), Technology (Chemical Methods, Separation Methods), Type, Distribution Channel, End User - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Hemoglobin A1c Testing Devices Global Market Report 2024 - Product Image

Hemoglobin A1c Testing Devices Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Forecast 2024-2030 - Product Image

Global Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From

About the HbA1C Testing Market

The HbA1C Testing market within the Biotechnology industry is a rapidly growing sector. It is used to measure the average amount of glucose in the blood over a period of two to three months. This test is used to diagnose and monitor diabetes, as well as to assess the effectiveness of diabetes treatments. It is also used to detect pre-diabetes and to monitor the risk of developing diabetes. The HbA1C Testing market is driven by the increasing prevalence of diabetes, the growing awareness of the importance of early diagnosis and treatment, and the availability of advanced testing technologies. The market is also supported by the increasing demand for point-of-care testing and the development of new products. Some of the major companies in the HbA1C Testing market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Alere, and Bio-Rad Laboratories. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.